Combined brachytherapy with external beam radiotherapy for localized prostate cancer: Reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy

Brachytherapy

Volumn 7, Issue 1, 2008, Pages 1-6

  Zelefsky, Michael J ^a   Nedelka, Michele A ^a   Arican, Zumre Lutfiye ^a   Yamada, Yoshiya ^a   Cohen, Gil'ad N ^a   Shippy, Alison M ^a   Park, Jessica J ^a   Zaider, Marco ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; IMRT; Prostate cancer; Radiation therapy; Toxicity

Indexed keywords

IODINE 125;

ADULT; ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM DISEASE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING; URETHRA STRICTURE; URINARY TRACT DISEASE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 39449121920     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.12.002     Document Type: Article

References (25)

1. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
3. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized Phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
4. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
5. Jani A.B., Hand C.M., Lujan A.E., et al. Biologic effective dose for comparison and combination of external beam and low dose rate interstitial brachytherapy prostate cancer treatment plans. Med Dosim 29 (2004) 42-48
6. Zaider M., Zelefsky M.J., Cohen G.N., et al. Methodology for biologically-based treatment planning for combined low dose-rate (permanent implant) and high dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 702-713
7. Lee W.R., Bae K., Lawton C., et al. Late toxicity and biochemical recurrence after external beam radiotherapy combined with permanent-source prostate brachytherapy: Analysis of Radiation Therapy Oncology Group study 0019. Cancer 109 (2007) 1506-1512
8. Albert M., Tempany C.M., Schultz D., et al. Late urinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiotherapy. Cancer 98 (2003) 949-954
9. Kang S.K., Chou R.H., Dodge R.K., et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 99-103
10. Sarosdy M.F. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer 101 (2004) 754-760
11. Zeitlin S.I., Sherman J., Raboy A., et al. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 160 (1998) 91-95
12. Zelefsky M.J., Yamada Y., Cohen G.N., et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 65-70
13. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 956-963
14. Wust P., von Borczyskowski D.W., Henkel T., et al. Clinical and physical determinants for toxicity of I-125 seed prostate brachytherapy. Radiother Oncol 73 (2004) 39-48
15. Prada P.J., Juan G., Fernandez J., et al. Conformal prostate brachytherapy guided by realtime dynamic dose calculations using permanent 125-Iodine implants-technical description and preliminary experience. Arch Esp Urol 59 (2006) 933-940
16. Stone N.N., and Stock R.G. Long-term urinary, sexual and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 69 (2007) 338-342
17. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419
18. Thames H., Kuban D., Levy L., et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929-943
19. Singh A., Zelefsky M.J., Raben A., et al. Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer. Int J Cancer 90 (2000) 275-280
20. Zaider M., Zelefsky M.J., Cohen G.N., et al. The role of external beam in brachytherapy. Future Oncol 3 (2007) 159-168
21. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
22. Ghaly M., Wallner K., Merrick G., et al. The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: Morbidity outcomes from two prospective randomized multicenter trials. Int J Radiat Oncol Biol Phys 55 (2003) 1288-1293
23. Neill M., Studer G., Le L., et al. The nature and extent of urinary morbidity in relation to prostate brachytherapy and urethral dosimetry. Brachytherapy 6 (2007) 173-179
24. Desai J., Stock R.G., Stone N.N., et al. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Investig 6 (1998) 135-141
25. Keyes M., Miller S., Mirvan V., et al. Acute and late urinary toxicity in 606 prostate brachytherapy patients-The BC Cancer Agency experience. [Abstract]. Brachytherapy 6 (2007) 91